312 related articles for article (PubMed ID: 16973390)
1. Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease.
Enzler T; Bonizzi G; Silverman GJ; Otero DC; Widhopf GF; Anzelon-Mills A; Rickert RC; Karin M
Immunity; 2006 Sep; 25(3):403-15. PubMed ID: 16973390
[TBL] [Abstract][Full Text] [Related]
2. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.
Pau E; Chang NH; Loh C; Lajoie G; Wither JE
Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847
[TBL] [Abstract][Full Text] [Related]
3. BAFF costimulation of Toll-like receptor-activated B-1 cells.
Ng LG; Ng CH; Woehl B; Sutherland AP; Huo J; Xu S; Mackay F; Lam KP
Eur J Immunol; 2006 Jul; 36(7):1837-46. PubMed ID: 16791880
[TBL] [Abstract][Full Text] [Related]
4. Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells.
Fletcher CA; Sutherland AP; Groom JR; Batten ML; Ng LG; Gommerman J; Mackay F
Eur J Immunol; 2006 Sep; 36(9):2504-14. PubMed ID: 16906535
[TBL] [Abstract][Full Text] [Related]
5. TLR4 promotes B cell maturation: independence and cooperation with B lymphocyte-activating factor.
Hayashi EA; Granato A; Paiva LS; Bertho AL; Bellio M; Nobrega A
J Immunol; 2010 May; 184(9):4662-72. PubMed ID: 20357250
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, Loucy.
Yoshimoto K; Takahashi Y; Ogasawara M; Setoyama Y; Suzuki K; Tsuzaka K; Abe T; Takeuchi T
Int Immunol; 2006 Jul; 18(7):1189-96. PubMed ID: 16740602
[TBL] [Abstract][Full Text] [Related]
7. B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus.
Parameswaran R; Ben David H; Sharabi A; Zinger H; Mozes E
Clin Immunol; 2009 May; 131(2):223-32. PubMed ID: 19188092
[TBL] [Abstract][Full Text] [Related]
8. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
9. Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice.
Fletcher CA; Groom JR; Woehl B; Leung H; Mackay C; Mackay F
J Autoimmun; 2011 Mar; 36(2):125-34. PubMed ID: 21216131
[TBL] [Abstract][Full Text] [Related]
10. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development.
Dejardin E
Biochem Pharmacol; 2006 Oct; 72(9):1161-79. PubMed ID: 16970925
[TBL] [Abstract][Full Text] [Related]
11. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
Lartigue A; Colliou N; Calbo S; François A; Jacquot S; Arnoult C; Tron F; Gilbert D; Musette P
J Immunol; 2009 Nov; 183(10):6207-16. PubMed ID: 19841185
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species augment B-cell-activating factor expression.
Moon EY; Lee JH; Oh SY; Ryu SK; Kim HM; Kwak HS; Yoon WK
Free Radic Biol Med; 2006 Jun; 40(12):2103-11. PubMed ID: 16785024
[TBL] [Abstract][Full Text] [Related]
13. Regulation of B cell self-tolerance by BAFF.
Brink R
Semin Immunol; 2006 Oct; 18(5):276-83. PubMed ID: 16916609
[TBL] [Abstract][Full Text] [Related]
14. Regulatory B cells in autoimmune diseases: how do they work?
Lemoine S; Morva A; Youinou P; Jamin C
Ann N Y Acad Sci; 2009 Sep; 1173():260-7. PubMed ID: 19758160
[TBL] [Abstract][Full Text] [Related]
15. Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells.
Grimaldi CM
Curr Opin Rheumatol; 2006 Sep; 18(5):456-61. PubMed ID: 16896282
[TBL] [Abstract][Full Text] [Related]
16. Survival signaling in resting B cells.
Patke A; Mecklenbräuker I; Tarakhovsky A
Curr Opin Immunol; 2004 Apr; 16(2):251-5. PubMed ID: 15023421
[TBL] [Abstract][Full Text] [Related]
17. BAFF, APRIL and their receptors: structure, function and signaling.
Bossen C; Schneider P
Semin Immunol; 2006 Oct; 18(5):263-75. PubMed ID: 16914324
[TBL] [Abstract][Full Text] [Related]
18. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome.
Groom J; Kalled SL; Cutler AH; Olson C; Woodcock SA; Schneider P; Tschopp J; Cachero TG; Batten M; Wheway J; Mauri D; Cavill D; Gordon TP; Mackay CR; Mackay F
J Clin Invest; 2002 Jan; 109(1):59-68. PubMed ID: 11781351
[TBL] [Abstract][Full Text] [Related]
19. BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus.
Stohl W; Xu D; Kim KS; Koss MN; Jorgensen TN; Deocharan B; Metzger TE; Bixler SA; Hong YS; Ambrose CM; Mackay F; Morel L; Putterman C; Kotzin BL; Kalled SL
Arthritis Rheum; 2005 Jul; 52(7):2080-91. PubMed ID: 15986357
[TBL] [Abstract][Full Text] [Related]
20. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE.
Ehlers M; Fukuyama H; McGaha TL; Aderem A; Ravetch JV
J Exp Med; 2006 Mar; 203(3):553-61. PubMed ID: 16492804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
